Francesca Taraballi’s Post

𝗪𝗵𝗼 𝗪𝗶𝗹𝗹 𝗙𝘂𝗻𝗱 𝗦𝗲𝗲𝗱 𝗥𝗼𝘂𝗻𝗱𝘀 𝗳𝗼𝗿 𝗠𝗲𝗱𝗧𝗲𝗰𝗵 𝗦𝘁𝗮𝗿𝘁𝘂𝗽𝘀? 𝗔𝗻𝗱 𝗪𝗵𝗲𝗻 𝗪𝗶𝗹𝗹 𝗜𝘁 𝗚𝗲𝘁 𝗘𝗮𝘀𝗶𝗲𝗿? The struggle for early-stage MedTech startups to secure seed funding is real—and I've seen it firsthand. Just last week, I read an insightful article in Nature Biotechnology (link in comments) that highlighted the current state of financing in Biotech. The findings are strikingly relevant to MedTech as well. Here’s the summary: • 𝗩𝗲𝗻𝘁𝘂𝗿𝗲 𝗰𝗮𝗽𝗶𝘁𝗮𝗹 𝗶𝘀 𝗳𝗹𝗼𝘄𝗶𝗻𝗴—but primarily into Series A, B, and C rounds for more mature startups with experienced leadership and proven technologies in clinical stages (later-stage development). • 𝗦𝗲𝗲𝗱 𝗳𝘂𝗻𝗱𝗶𝗻𝗴, 𝗵𝗼𝘄𝗲𝘃𝗲𝗿, 𝗶𝘀 𝘀𝗰𝗮𝗿𝗰𝗲. Investors are hesitant to back startups in the pre-clinical stages, where core technologies still need significant de-risking (early-stage development). This has created a polarized environment of "haves" and "have-nots." 𝗪𝗵𝘆 𝘁𝗵𝗲 𝗰𝗼𝗻𝘀𝗲𝗿𝘃𝗮𝘁𝗶𝘃𝗲 𝗮𝗽𝗽𝗿𝗼𝗮𝗰𝗵? Higher interest rates and an abundance of attractive, lower-risk clinical-stage companies emerging from the pandemic's peak years mean investors can choose less risky opportunities at appealing valuations. 𝗦𝗼, 𝘄𝗵𝗲𝗻 𝘄𝗶𝗹𝗹 𝗲𝗮𝗿𝗹𝘆-𝘀𝘁𝗮𝗴𝗲 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗮𝘁𝘁𝗿𝗮𝗰𝘁 𝗺𝗼𝗿𝗲 𝗳𝘂𝗻𝗱𝗶𝗻𝗴? It’s hard to say. But one thing is clear: For the Biotech and MedTech sectors to keep growing, we’ll need fresh, innovative technologies. And that can only happen if we start fueling early-stage startups again. Let’s hope that day comes sooner rather than later. #Medtech #Biotech #MedicalDevices #Innovation

https://lnkd.in/daNHPgyq I've found this article that I'm happy to share💡 The biotech funding landscape is evolving, and this post explores game-changing strategies. 🚀 Embracing global incentives, connecting with seed investors, and tapping into university resources – it's about breaking barriers for startups. How do you fund innovation in biotech? 💬 #BiotechFunding #Innovation #StartupInsights #CEDEBIO #Biotech #StartupFunding #Entrepreneurship #Innovation #GlobalStrategies #VentureSupport #ResearchIncentives #CollaborativeBiotech #FundingIdeas #BioTechTalks

🚀 ⏰ 6-Day Countdown to the 10x Accelerator! Yesterday, we highlighted the Defence 10x stream. Today, let's delve into the #molecular world of the Bio10x stream (B10x), part of our #unswfounders 10x Accelerator. The #Bio10x Accelerator provides bespoke support tailored for startups engineering biology to create new products. This is the platform where ambitious biotech founders can find the specialised resources and guidance needed to navigate the unique challenges of the biotech industry, particularly in navigating the complex, costly, and regulatory-heavy path from scientific discovery to commercial success. ⁇ Why Should #Biotech #Startups Apply⁇ 🎯 Targeted Support: As one of only six startups selected, receive personalised mentoring and extensive 1:1 support designed to foster significant growth and innovation. 🗺️ Experience Guidance: Benefit from the leadership of Maddison McCoy, our Program Manager, who has extensive experience in the biotech sector. Maddison provides essential support in crossing the 'valley of death' from discovery to market viability, making her an invaluable asset to any #BiotechEntrepreneur. 💪 Robust Resources: B10x is more than just an accelerator; it’s a pathway to integrating your biotech solutions into broader markets. Applicants will be considered for up to $30,000 worth of analytical services at Bioplatforms Australia such as proteomics and genomics, critical for product development and innovation➕ Access premier #PC2labs at UNSW ’s School of Biotechnology and Biomolecular Sciences, ensuring a safe and controlled environment for your pivotal experiments and research 🌱Seed Funding: Secure a $20,000 investment through a #SAFE (#SimpleAgreementforFutureEquity), offering founder-friendly terms to help kickstart your journey. 📅 Applications Close: May 20th. 🔍 Ready to Apply or Learn More? Click here: https://lnkd.in/g2-Wc_fF #Biotech #Innovation #accelerator #Startups #unsw David Burt Dina Titkova Cauldron Ferm Michele Stansfield Psylo 🧪 Joshua Ismin

Among the reasons I like working at UMN. Beyond the numbers and the records, it's especially exciting to dig deeper into the companies coming out of this Univ/program.

Did you know that KIC DC's Bio I-Corps-Tech Lean Innovation Program is a three-year initiative dedicated to facilitating the soft landing of Korean biotech startups in the US market? Over the course of three years, the participating Korean startups undergo training, workshops, and consulting sessions, with the goal of establishing their business in the US by the program's conclusion. The year 2023 marked the completion of the program for Myo-Tec-Sci, NeuroEars, RUDACURE, and STEMDEN. Throughout the program, these innovative Korean startups expanded their US investor network, secured new rounds of investments, established partnerships with leading corporations and universities, and recruited new talent to advance their technologies. These teams also visited Washington, DC last November to participate in Defy Conference, where they had the opportunity to meet potential investors and customers. Share your congratulations and best wishes for these startups in the comments below! #KICWashingtonDC #KoreaInnovationCenter #KICDC #BioTech #Accelerator #KoreanStartup

Why Do Most Biotech Startups Fail? (And How to Beat the Odds) 🤔 The biotech industry is booming, but the path to success is fraught with challenges. The harsh reality is that most biotech startups don't make it. Why? It's not just about the science. In my latest newsletter, I dive deep into the five crucial factors that separate the thriving biotechs from those that falter. We'll explore: 🔻 The #1 mistake that can sink even the most promising idea 👨💼 The critical leadership skills that go beyond scientific expertise 📉 How to avoid common financial pitfalls that plague many startups 🎯 Why understanding your market is just as important as your technology 🤝 The power of partnerships and collaborations in the biotech world Whether you're a founder, investor, or simply fascinated by the biotech industry, this is essential reading. Get the full story and insights in my latest newsletter. Dive deeper into these topics this Thursday in my next livestream: [https://lnkd.in/gh-tJs-A] #biotech #startups #innovation #entrepreneurship #leadership

Excited to share! My article on Mastering The Biotech Startup Journey has just been published in the Life Sciences Review magazine, under the BioTech Startup section. If you're interested in all things BioTech, be sure to check it out! #LifeSciences #BioTechStartup #Innovation https://lnkd.in/eZ8P6v6k

When Gary Niehaus began teaching at NEOMED in 1985, the landscape of #research and #invention was vastly different. Back then, academics were mainly focused on creating theoretical work, leaving the business application to others. Fast forward to today, Ohio's #universities are hubs of #innovation, thanks in part to initiatives like NEOMED’s Research, Entrepreneurship, Discovery, and Innovation Zone The REDIzone supports local #lifescience and #biomedical entrepreneurs with resources and expert connections, fostering groundbreaking advancements. It helps to improve #globalhealth while supporting regional startups. The incubator provides office and wet lab spaces essential for biotech research, making it a vital resource for companies like Crystal Diagnostics CDx and BioMendics, LLC. Ohio is proving that biotech innovation can flourish outside traditional hotspots like Boston or San Francisco. With incredible talent and support from institutions like NEOMED, the future of biotech in Ohio looks bright! 🌟🔬 #Innovation #Biotech #OhioProud #NEOMED #REDIzone #Entrepreneurship #HealthTech #StartupSuccess #Research #MedicalAdvancements Thanks for sharing our story Ideastream Public Media. Jordan Walker Karen McGuire John Langell, MD, PhD, MPH, MBA, FACS Read more about the RediZone: https://ow.ly/R6eh50ST00b

We are delighted to announce that Whale Tank 2.0 is collaborating with IKP Knowledge Park, a premier Science Park dedicated to fostering innovation in the life sciences and related fields. Located in Genome Valley, Hyderabad, IKP spans a 200-acre pollution-free zone, offering a world-class ecosystem for cutting-edge research and development. IKP Knowledge Park boasts a mix of ready-to-use, multi-tenanted modular wet laboratory blocks (Innovation Corridors) with shared facilities and support services, as well as developed land for customized R&D facilities. Currently, the 140,000 sqft Innovation Corridor with a 84,000 sqft wet laboratory space, thus providing an ideal environment for innovative companies. We are grateful to IKP Team for their invaluable support, commitment, and participation in FABA’s Whale Tank 2.0. Whale Tank 2.0, scheduled for August 17th, 2024, at the University of Hyderabad, will bring together the most innovative life sciences startups to pitch their ideas to top-tier venture capitalists, industry leaders, and fellow entrepreneurs. This event serves as a unique platform to showcase cutting-edge solutions in biotechnology, medical devices, pharmaceuticals, diagnostics, digital health, AI in drug discovery & development, and agritech. Life Sciences Startups, VCs, and Incubators, this is your chance to be part of a transformative event! Startups: Pitch your groundbreaking innovations and gain visibility with leading investors. VCs: Discover pioneering startups and explore potential investment opportunities. Incubators: Nominate your top startups and help them connect with global investors. Register now to be part of Whale Tank 2.0: https://lnkd.in/gR5-V8Ta. For any inquiries, feel free to contact us at coo@biofaba.org.in. Let’s unite to drive innovation and foster growth in the life sciences sector. We look forward to your participation! #WhaleTank2024 #Innovation #VentureCapital #Startups #FABA #Entrepreneurship #InvestmentOpportunity #Growth #LifeSciences #IKP #Incubation #GenomeValley

📌 The National Institutes of Health Grants are a gold mine for biotech companies! 💰 With over 300 grant programs available each year, there's something for every stage of research and development. Whether you're an early-stage biotech or a more mature company, there's a program for you. The Small Business Innovation Research(SBIR) grants are perfect for early-stage biotech startups, offering up to $2 million non-dilutive capital for exploring innovative concepts.🌟🔬 And as you grow, the larger "R" grants can support clinical research and commercialization. It's all about doing your homework, crafting a compelling application, and a little bit of luck, but NIH funding could be a total game changer for your company. 🚀 👉 Don't miss out on this incredible opportunity to take your biotech startup to the next level! via Narine Emdjian, MBA #startup #biotech #healthcare #medtech #innovation #tech #funding #sbir #fundingopportunity #opportunity #tipoftheday #tipsandtricks